ESMO 2024 Highlights: Presenter Vignette – Hildur Helgadottir

Dr. Hildur Helgadottir

Hildur Helgadottir

MD, PhD

Karolinska Comprehensive Cancer Center

Abstract# 1079MO

Survival before and after the Introduction of Adjuvant Treatment in Stage III Melanoma: A Nationwide Registry-Based Study